The quest for a vaccine to address the AIDS problem appears to be progressing in the right direction. On Thursday, scientists reported that an experimental vaccine was able to protect half the monkeys in batch against a virus similar to that of AIDS.
Johnson and Johnson, a household name for long is involved with this research and has already been trying the vaccine in humans. According to experts in vaccine, a new approach is essential to protect from a virus that has resisted every effort to stop it.
Mitchell Warren of HIV vaccine and treatment advocacy group said that it was quite promising according to him. He added that in the 20 years history of AVAC a bunch of products have been examined but they never reached the stage of efficacy trials and most of them eventually failed. Warren however did not participate in the latest studies.
According to the two studies reported in journal Science, the two step vaccine not only protected half the monkeys, but their bodies also produced antibodies that were measurable thus demonstrating how well the monkeys were protected.